Last updated 2026-07-26
- Raised $8.3M Undisclosed Round led by S2G Investments, Aug 2023
- Raised $4.3M Undisclosed Round led by Nutreco, May 2021
- Raised grant, Dec 1969
Total raised
$12.6M
Last: Undisclosed Round 2023-09
Stage
Seed
Founded
2014
Headcount
14
HQ
Haifa, Israel
Sector
Agriculture & Food Technologies
About
ViAqua Therapeutics is an Israeli biotechnology company that has developed an orally administered RNA-particle platform to promote and improve animal health in aquaculture. The company's platform utilizes a proprietary RNAi formulation that triggers the immune system and prevents viral infections. The coated particles are delivered via feed to produce the maximum effect and reduce cost. ViAqua's initial product is an RNA-based solution for application against the White Spot Shrimp Virus (WSSV) pandemic, a major challenge in the aquaculture industry.
Funding history · 3 rounds · $12.6M total
2023-08
Undisclosed Round
$8.3M
★ S2G InvestmentsNutrecoAgrilineRabobankI-Lab AngelsCircle Investments
2021-05
Undisclosed Round
$4.3M
★ Nutreco★ Technion★ Agriline★ Clay Capital★ S2G Investments★ Thai Union Group
1969-12
Grant
Undisclosed
Headcount over time
From 6 (2020-02) to 15 (2026-03) · +9 (+150%) · 25 points · source: Finder history + radar grounding
Q&A
- What is ViAqua Therapeutics' primary focus?
- ViAqua Therapeutics is an Israeli biotechnology company that develops orally administered RNA-particle platforms to improve animal health and prevent viral epidemics in aquaculture.
- What is ViAqua Therapeutics' initial product designed to address?
- ViAqua Therapeutics' initial product is an RNA-based solution targeting the White Spot Shrimp Virus (WSSV) pandemic, a significant challenge in the aquaculture industry.
- When was ViAqua Therapeutics founded?
- ViAqua Therapeutics was founded in 2014.
- How much funding has ViAqua Therapeutics raised in total?
- ViAqua Therapeutics has raised a total of $17.6 million USD.
- When did ViAqua Therapeutics complete its A Round funding, and who was a lead investor?
- In September 2023, ViAqua Therapeutics completed an A Round funding of $8.25 million USD, with.
- When did ViAqua Therapeutics secure its Seed funding, and who was a lead investor?
- In June 2021, ViAqua Therapeutics announced a Seed investment of $4.3 million USD, led by.
- What is the current employee count range for ViAqua Therapeutics?
- ViAqua Therapeutics has 11-50 employees.
- Where is ViAqua Therapeutics headquartered?
- ViAqua Therapeutics is headquartered in Haifa, Israel.
Team · 2
Shai Ufaz
Founder · Co-founder & CEO
Shai Einbinder
Founder · Co-founder
Sectors & technology
Primary sector
Agriculture & Food Technologies
Sub-sectors
Climate TechFood & Land UseSustainable FarmingHealth Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryAgriculture & Food TechnologiesAg TechFarm Equipment & Treatment
Technologies
Biologicals
Target customers
Agriculture & FoodMarine LifeFishSea Food
Business model
B2B
Highlights
Verified
Tags
sustainable-farmingtherapeuticsviral-diseasesfish-farmsagtechaquacultureclimate-techdrug-deliveryfarmersagriculturedisease-management
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | viaqua-t.com |
|---|---|
| linkedin.com/company/34752747 |
Identifiers & details
| Legal name | ViAqua Therapeutics Ltd. |
|---|---|
| Founded | 2014 |
| Employees (exact) | 14 |
| Offices | Haifa |
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | viaqua-t.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515130250 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2014-09-16 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 5 — shares_capital (4), annual_report (1) |
| Registered address | שד רוז 1 חיפה |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-30 | הקצאת מניות |
| 2026-01-29 | דו~ח שנתי-שינוי בהוראות בתקנון |
| 2026-05-27 | העברת מניות |
| 2026-03-19 | הגדלה של הון רשום |
| 2026-06-07 | שינוי בהרכב הון - מניות-הפחתת הון מוקצה |